France, April 28 -- France based NOVALIX has secured contract from SATT OUEST VALORISATION for Research and Experimental Development Services - Integrated study of a chemical compound with therapeutic purposes: from synthesis to admme/pk characterization and in vivo efficiency. The value of the contract is worth 27000000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....